首页> 美国卫生研究院文献>PLoS Clinical Trials >Residual Baculovirus in Insect Cell-Derived Influenza Virus-Like Particle Preparations Enhances Immunogenicity
【2h】

Residual Baculovirus in Insect Cell-Derived Influenza Virus-Like Particle Preparations Enhances Immunogenicity

机译:昆虫细胞衍生的流感病毒样颗粒制剂中的残留杆状病毒可增强免疫原性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Influenza virus-like particles are currently evaluated in clinical trials as vaccine candidates for influenza viruses. Most commonly they are produced in baculovirus- or mammalian- expression systems. Here we used different vaccination schemes in order to systematically compare virus-like particle preparations generated in the two systems. Our work shows significant differences in immunogenicity between the two, and indicates superior and broader immune responses induced by the baculovirus-derived constructs. We demonstrate that these differences critically influence protection and survival in a mouse model of influenza virus infection. Finally, we show that the enhanced immunogenicity of the baculovirus-derived virus-like particles is caused by contamination with residual baculovirus which activates the innate immune response at the site of inoculation.
机译:目前在临床试验中将类流感病毒颗粒作为流感病毒的候选疫苗进行评估。最常见的是,它们是在杆状病毒或哺乳动物表达系统中产生的。在这里,我们使用了不同的疫苗接种方案,以便系统地比较在两个系统中生成的病毒样颗粒制剂。我们的工作显示了两者之间在免疫原性上的显着差异,并表明由杆状病毒衍生的构建体诱导的优越和广泛的免疫应答。我们证明这些差异严重影响流感病毒感染的小鼠模型中的保护和生存。最后,我们表明杆状病毒来源的病毒样颗粒的增强的免疫原性是由残留的杆状病毒污染引起的,该残留的杆状病毒激活了接种部位的先天免疫应答。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号